Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2005 1
2006 1
2008 1
2009 2
2010 1
2014 2
2015 1
2016 1
2019 1
2020 2
2021 1
2022 2
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Results by year

Filters applied: . Clear all
Page 1
Ubiquitination of Myc: flipping the switch.
Boquoi A, Enders G. Boquoi A, et al. Cancer Biol Ther. 2006 Aug;5(8):907-8. doi: 10.4161/cbt.5.8.3229. Epub 2006 Aug 26. Cancer Biol Ther. 2006. PMID: 16969074 Review.
Widespread amyloidogenicity potential of multiple myeloma patient-derived immunoglobulin light chains.
Sternke-Hoffmann R, Pauly T, Norrild RK, Hansen J, Tucholski F, Høie MH, Marcatili P, Dupré M, Duchateau M, Rey M, Malosse C, Metzger S, Boquoi A, Platten F, Egelhaaf SU, Chamot-Rooke J, Fenk R, Nagel-Steger L, Haas R, Buell AK. Sternke-Hoffmann R, et al. Among authors: boquoi a. BMC Biol. 2023 Feb 3;21(1):21. doi: 10.1186/s12915-022-01506-w. BMC Biol. 2023. PMID: 36737754 Free PMC article.
A phase I first-in-man study to investigate the pharmacokinetics and safety of liposomal dexamethasone in patients with progressive multiple myeloma.
Metselaar J, Lammers T, Boquoi A, Fenk R, Testaquadra F, Schemionek M, Kiessling F, Isfort S, Wilop S, Crysandt M. Metselaar J, et al. Among authors: boquoi a. Drug Deliv Transl Res. 2023 Apr;13(4):915-923. doi: 10.1007/s13346-022-01268-6. Epub 2023 Jan 2. Drug Deliv Transl Res. 2023. PMID: 36592287 Free PMC article. Clinical Trial.
Efficacy and Tolerability of High- versus Low-dose Lenalidomide Maintenance Therapy of Multiple Myeloma after Autologous Blood Stem Cell Transplantation.
Fenk R, Giagounidis A, Goldschmidt H, Heinsch M, Rummel M, Kroger N, Boquoi A, Lopez D, Gerrlich C, Baier J, Liesenjohann S, Hauck K, Savickaite I, Mai EK, Aul C, Strapatsas J, Dienst A, Kondakci M, Haas R, Kobbe G. Fenk R, et al. Among authors: boquoi a. Clin Cancer Res. 2020 Nov 15;26(22):5879-5886. doi: 10.1158/1078-0432.CCR-20-0841. Epub 2020 Aug 17. Clin Cancer Res. 2020. PMID: 32817078
Health-Related Quality of Life in Multiple Myeloma Patients Treated with High- or Low-Dose Lenalidomide Maintenance Therapy after Autologous Stem Cell Transplantation-Results from the LenaMain Trial (NCT00891384).
Boquoi A, Giagounidis A, Goldschmidt H, Heinsch M, Rummel MJ, Kröger N, Mai EK, Strapatsas J, Haas R, Kobbe G. Boquoi A, et al. Cancers (Basel). 2023 Oct 26;15(21):5157. doi: 10.3390/cancers15215157. Cancers (Basel). 2023. PMID: 37958331 Free PMC article.
18 results